Loading...
•
Dec 31, 2021
Medpace Q4 2021 Earnings Report
Medpace's Q4 2021 financial results were reported, showing revenue growth and strategic advancements.
Key Takeaways
Medpace Holdings, Inc. announced its Q4 and full year 2021 financial results, with Q4 revenue reaching $308.6 million, an 18.8% increase year-over-year, and net new business awards totaling $458.7 million, up 27.9% from the previous year. GAAP net income for Q4 was $50.0 million, or $1.32 per diluted share. The company provided financial guidance for 2022, forecasting revenue between $1.400 billion and $1.460 billion.
Q4 2021 revenue increased by 18.8% to $308.6 million compared to Q4 2020.
Net new business awards for Q4 2021 rose by 27.9% to $458.7 million, resulting in a book-to-bill ratio of 1.49x.
GAAP net income for Q4 2021 was $50.0 million, or $1.32 per diluted share.
The company forecasts 2022 revenue in the range of $1.400 billion to $1.460 billion.
Forward Guidance
The Company forecasts 2022 revenue in the range of $1.400 billion to $1.460 billion, representing growth of 22.6% to 27.8% over 2021 revenue of $1.142 billion. GAAP net income for full year 2022 is forecasted in the range of $204.0 million to $216.0 million. Additionally, full year 2022 EBITDA is expected in the range of $262.0 million to $278.0 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...